VANCOUVER, BC / ACCESS Newswire / October 24, 2025 / StimCell Energetics Inc. (OTCQB:STME) ("StimCell" or the "Company"), a biotech pioneer targeting cellular energy to enhance wellness, anti-aging, and longevity, is pleased to announce its successful uplisting to the OTCQB Venture Market, effective October 24, 2025. This significant milestone reflects the company's commitment to enhancing transparency, improving liquidity, and expanding its visibility within the investment community.
The OTCQB, operated by OTC Markets Group, is a premier marketplace for early-stage and developing companies that meet high standards of financial reporting and corporate governance. By uplisting to the OTCQB, StimCell demonstrates its dedication to providing shareholders with greater access to financial information and a more robust trading platform.
"We are happy to achieve this uplisting to the OTCQB market, a key step in our growth strategy," said David Jeffs, Chief Executive Officer of StimCell Energetics Inc. "This move enhances our ability to attract new investors and supports our mission to bring our unique eBalance® wellness device, a cutting-edge solution designed to promote cellular energy maximization, to market. We look forward to leveraging this platform to further our business objectives and create long-term value for our shareholders."
The uplisting to OTCQB aligns with StimCell Energetics Inc.'s ongoing efforts to strengthen its market presence and advance its innovative projects through both research and market saturation while maintaining the highest standards of operational and financial transparency.
About StimCell Energetics Inc.
StimCell Energetics Inc. is a biotech company focused on the discovery, development and commercialization of therapeutic and non-therapeutic products that enhance cellular function, promote general wellness and alleviate health complications including, but not limited to: aging, insulin sensitivity, high blood pressure, neuropathy and kidney function. The Company's main focus is on continued research and development of its eBalance® Technology and its eBalance® Home System.
On behalf of the Board of Directors of StimCell Energetics Inc.
David Jeffs
CEO, Director
For further information:
info@stimcell.com
www.StimCell.com
Forward Looking Statements
This press release contains forward-looking statements. Forward-looking statements are subject to risks, uncertainties and assumptions and are identified by words such as "expects", "intends", "estimates", "projects", "anticipates", "believes", "could", and other similar words. All statements addressing product performance, events, or developments that the Company expects or anticipates will occur in the future are forward-looking statements. Because the statements are forward-looking, they should be evaluated in light of important risk factors and uncertainties, some of which are described in the Company's Quarterly, Annual and Current Reports filed with the United States Securities and Exchange Commission (the "SEC"). Should one or more of these risks or uncertainties materialize, or should any of the Company's underlying assumptions prove incorrect, actual results may vary materially from those currently anticipated. In addition, undue reliance should not be placed on Company's forward-looking statements. Except as required by law, StimCell Energetics Inc. disclaims any obligation to update or publicly announce any revisions to any of the forward-looking statements contained in this press release. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. No stock exchange, securities commission or other regulatory body has reviewed nor accepts responsibility for the adequacy or accuracy of this release. Investors are advised to carefully review the reports and documents that StimCell Energetics Inc. files from time to time with the SEC, including its Annual, Quarterly and Current Reports.
SOURCE: StimCell Energetics Inc.
View the original press release on ACCESS Newswire